Specifically, by increasing extracellular Pi, at concentrations observed in CKD, we demonstrate that hyperphosphatemia inhibits the CaSR in a noncompetitive manner and thus increases PTH secretion. The gene discussed is PTH; the disease is hyperphosphatemia.